![]() |
| Manu Mittal & Anshul Mittal - Co-founders of Zanskar |
The funds will be deployed to expand Zanskar’s product portfolio, scale up marketing across digital platforms, and enhance distribution through both D2C and offline retail channels. A portion of the capital will also be invested in building a dedicated R&D vertical focused on chronic pain and recovery.
Born out of a personal journey of the founders, Zanskar was created to address the unmet needs of people struggling with chronic pain. The co-founders, who first met as classmates at IIT Delhi, shared a vision to build a brand that blends science with accessibility. Together, they developed proprietary, science-backed formulations for joint pain, migraines, back pain, and arthritis. Today, its flagship products, including the joint pain cream with Vitamin B6 and migraine relief roll-on with magnesium, have reached over 50,000 customers across India and emerged as category leaders online.
The timing could not be more opportune. According to industry sources, India’s pain-relief market, covering sprays, creams, and pills, has more than doubled in the last five years to around ₹16,000 crore (USD 2 billion). Analgesics and topical rubefacients alone surged from ₹6,820 crore in 2020 to nearly ₹15,905 crore in 2025, growing at an annual rate of 18 percent, almost three times faster than the overall OTC market. Unlike generic OTC products that often rely on chemical-heavy formulations, Zanskar differentiates itself by blending clinical validation with clean, effective ingredients, offering efficacy without side effects.
Anshul Mittal & Manu Mittal, Co-founders of Zanskar, jointly said, “This round is a huge validation of our belief that pain relief doesn’t need to come with a trade-off. We’re excited to partner with Zeropearl to take Zanskar to more homes across India and continue building products that actually work and that people love using.”
Speaking on the investment, Bipin Shah, Managing Partner, Zeropearl VC, said: “At Zeropearl, we look for brands that are solving real & deep problems with authenticity & innovation. Zanskar’s approach to pain care by combining science with empathy really stood out of the box for us. We believe the team is well-positioned to build a trusted and scalable brand in a category that impacts millions of people in India and overseas.”
Looking ahead, Zanskar is preparing to launch new product formats targeting arthritis and muscle recovery, alongside expanding its AI-driven physiotherapy app to deliver personalized, at-home pain management protocols. The brand is also exploring early pilots in physiotherapy-led wellness centers in select metro cities, further strengthening its full-stack approach to pain relief.
Zanskar products are currently available through the brand’s website as well as leading platforms such as Blinkit, Tata 1mg, Amazon, and Flipkart.

IndianWeb2.com is an independent digital media platform for business, entrepreneurship, science, technology, startups, gadgets and climate change news & reviews.
No comments
Post a Comment